重松貿易 大阪本社 Official site

Library of bioactive compounds

Rich activity and target information are useful for initial hit exploration based on phenotypic and activity changes!

The "Bioactive Compound Library" is a screening compound library from MedChemExpress. It facilitates the construction of hypotheses regarding the signaling pathways and molecular mechanisms underlying phenotypic changes based on abundant compound information. It is useful for candidate exploration, sensitivity confirmation, reproducibility evaluation, and system validity confirmation through positive controls in the development of new assay systems. 【Features】 ■ Over 20,000 known bioactive compounds ■ Approved/clinical trial compounds, natural products, novel compounds, etc. ■ Easy to conduct discussions using target, pathway, and disease-related information ■ Useful for phenotype screening and mechanism research *For more details, please refer to the related links or feel free to contact us.

Related Link - https://www.shigematsu-bio.com/pickup/mce-bioactiv…

basic information

【Customization Items】 ■01 Type of Compound ■02 Volume ■03 Separate Plates ■04 Concentration ■05 Solution/Solid *For more details, please refer to the related links or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

【Suitable Research Applications】 ■Hit Discovery ■Phenotype Screening ■Signal Pathway Analysis ■Disease Mechanism Research ■Drug Repurposing ■Secondary Screening *For more details, please refer to the related links or feel free to contact us.

MCE_HY-L001_Bioactive Compound Library (260501)

PRODUCT

MCE_Compound Library Handbook

CATALOG

Recommended products

Distributors

Rohmatsu Trading Co., Ltd. engages in the procurement, research, and contracting of overseas chemical products, as well as providing information on them. From the top management to all employees, we unite as one, always keeping five keywords in mind, continuously striving for creativity and ingenuity, and serving the market to contribute to society.